Orthogon Therapeutics
Canton
About Orthogon Therapeutics
Orthogon Therapeutics is a preclinical-stage drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets. It focuses on the development of antiviral drugs for immune-suppressed patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.6M
- Last round: Series Unknown (Dec 2024)
- Website: orthogontherapeutics.com
- Phone: 339-502-9108
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orthogon-therapeutics-90776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.